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A number of microtubule (MT)-stabilizing agents (MSAs) have demonstrated or predicted potential as
anticancer agents, but a detailed structural basis for their mechanism of action is still lacking. We have
obtained high-resolution (3.9–4.2 Å) cryo-electron microscopy (cryo-EM) reconstructions of MTs stabilized by
the taxane-site binders Taxol and zampanolide, and by peloruside, which targets a distinct, non-taxoid pocket
on β-tubulin. We find that each molecule has unique distinct structural effects on the MT lattice structure.
Peloruside acts primarily at lateral contacts and has an effect on the “seam” of heterologous interactions,
enforcing a conformation more similar to that of homologous (i.e., non-seam) contacts by which it regularizes
the MT lattice. In contrast, binding of either Taxol or zampanolide induces MT heterogeneity. In doubly bound
MTs, peloruside overrides the heterogeneity induced by Taxol binding. Our structural analysis illustrates
distinct mechanisms of these drugs for stabilizing the MT lattice and is of relevance to the possible use of
combinations of MSAs to regulate MT activity and improve therapeutic potential.© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Microtubules (MTs) are crucial components of the
cytoskeleton and play a central role in cell division.
MTs are made of αβ-tubulin that assembles longitu-
dinally into protofilaments (PFs). About 13 PFs are
associated laterally, making the MT wall. Essential to
MT function is the property of dynamic instability,
the stochastic switching between MT growing and
shrinking linked to GTP binding and hydrolysis [1].
MT dynamics are tightly regulated in vivo by a
number of MT-associated proteins (MAPs) [2,3].
Widely successful antimitotic chemotherapeutics,
such as Taxol, bind to and stabilize MTs, inhibitingAuthors. Published by Elsevier Ltd. This
org/licenses/by-nc-nd/4.0/).dynamic instability and preventing cells from dividing
[4,5]. Taxol and other stabilizing compounds also
interfere with interphase MTs [6], thus affecting
many essential cellular processes. Since its discov-
ery [7], Taxol has been the subject of many studies
aimed at identifying its mechanism of action [8].
Taxol binds to a pocket in β-tubulin [9] that faces
the MT lumen and is near the lateral interface
between PFs [9–11] (Fig. 1). This lateral interface is
inherently flexible, as in vitro MTs can have different
numbers of PFs, ranging typically from 12 to 15
[12,13]. A hinge-like mechanism, involving the
“M-loop”, appears to accommodate the variation in
MT diameter with little change in the tubulin structureis an open access article under the CC BY-NC-ND license
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Fig. 1. Schematic of an MT and the binding sites for three MSAs. Taxol and zampanolide bind to the same lumenal
binding pocket, whereas peloruside binds to a pocket located on the MT exterior. A schematic for the dimer shows the
position of the N- and E-site nucleotides. The schematic for two dimers shows the distances between nucleotides that we
refer to in the text as intra- and interdimer. The molecular structure for the three drugs used in this study is also shown.
634 Cryo-EM Structures of Drug-Stabilized Microtubules[14]. While MTs formed in vitro have predominantly
13 and 14 PFs in the absence of binding factors or
tubulin-targeting drugs, in the presence of Taxol, the
distribution shifts to mostly 12 and 13 PFs [15,16],
suggesting that Taxol has an effect on the lateral
interface. On the other hand, Taxol has been shown to
straighten individual PFs [17], suggesting an effect at
the longitudinal interface between tubulin subunits.
More recently, high-resolution cryo-electron
microscopy (cryo-EM) studies comparing MTs in
different nucleotide states have indicated that GTP
hydrolysis leads to a compaction at the longitudinal
interdimer interface, adjacent to the nucleotide in
β-tubulin [11,18]. Interestingly, Taxol seems to reverse,
at least partially, the effect of GTP hydrolysis, giving
rise to a more expanded lattice after GTP hydrolysis
[11,15,18]. Because the resolution in previous studies
with Taxol [11] was limited to 5.5 Å, it was not possible
to describe the details of this Taxol-induced lattice
expansion, and the allosteric mechanism that links the
Taxol-binding pocket to the longitudinal interfaces
remains unknown.
Numerous cancer research efforts have been
directed toward finding other natural small molecules
that exert stabilizing effects similar to those of Taxol or
toward synthesizing Taxol-like analogs. As a result,a growing number of taxane and non-taxane MT-
stabilizing agents (MSAs) have been identified. Today,
there is a plethora of structurally diverse MSAs,
including epothilone [19], zampanolide [20], peloruside
[21], discodermolide [22], and laulimalide [23], among
others. In some cases, their binding site on tubulin has
been described in atomic detail [24,25] in X-ray crystal
structures of unassembled tubulin that, however,
lacked information concerning the effect of these
agents on the assembled MT structure. Many of
these agents (such as epothilone and zampanolide)
target the Taxol-binding pocket on the MT lumen
and are generally known as taxane-site binders.
Zampanolide is also known to form a covalent bond
at the taxoid site [26]. Peloruside and laulimalide
recognize a pocket on the surface of tubulin that faces
the MT exterior [25]. The overall effects of peloruside
and laulimalide are, however, similar to those of
Taxol-site MSAs: MTs assemble more efficiently in
their presence [27], and they inhibit MT dynamic
instability [28] and cell division [29]. It has been
described that the combined effect of a Taxol-site
MSA (Taxol) with a peloruside-site MSA (referred to
as doubly bound) results in a synergistic promotion of
MT assembly and stabilization [30,31]. On the other
hand, mechanical properties of the MT lattice appear
635Cryo-EM Structures of Drug-Stabilized Microtubulesto be governed by one drug over the other [32],
suggesting that the structural effects of a particular
drug may dominate.
In spite of progress over the years, a complete
understanding of the stabilizing mechanism of MSAs
remains elusive. Knowledge of how Taxol and other
small molecules affect MT structure would not only
contribute to our understanding of MT dynamic
instability but also provide crucial guidance to improve
MSA design in efforts toward cancer treatment.
Previous crystallographic studies have focused on
the contribution of MSAs to the stabilization of the
M-loop in β-tubulin, proposing as a mode of action the
facilitation of lateral contacts between PFs [24,25].
Consistent with this idea, changes outside the
drug-binding pocket are minimal in those crystal
structures, suggesting that drugs either do not
impact the global conformation of tubulin or,
alternatively, that crystallization conditions or crystal
packing overrides the effects of the drug. If the latter
were the case, then the effects of the drug on tubulin
structure could be more extensive in an MT lattice
context, as it has proven to be the case concerning
the state of the exchangeable (E-site) nucleotide in
tubulin [11,18].
To characterize any such structural effects on the
MT lattice and gain further insight into the mecha-
nism of action of MT stabilizers, we have produced
near-atomic resolution (3.9–4.2 Å) cryo-EM maps of
MTs bound to three structurally diverse MSAs. We
find that peloruside and the taxane-site binders
Taxol and zampanolide have very different effects
on MT lattice structure, suggesting distinct stabilizing
mechanisms. Peloruside acts as a “wedge”, affect-
ing lateral contacts, most prominently at the seam.
Taxol and zampanolide, which bind to the same site
on tubulin, produce distinct lattice structures, and
both give rise to structural heterogeneity in the MT
walls. Finally, we find that peloruside in the doubly
bound structure overrides the heterogeneity induced
by Taxol in the doubly bound structure. In all three
cases, the drug-induced changes in the structure of
the tubulin dimer are small but produce significant
and distinctive changes in the MT lattice.Results
When differences between α- and β-tubulin are
ignored, the arrangement of tubulin subunits in the MT
follows a helical path, most commonly a three-start
helix as depicted in Fig. 1. However, when the
differences between α- and β-tubulin are taken into
account, this helical symmetry is broken at the “seam”,
a discontinuity in the lateral contacts where interac-
tions are heterotypic (α-β and β-α), in contrast with the
rest of homotypic contacts around the MT cylinder.
Nonetheless, helical symmetry can be used to relate
two tubulin subunits in adjacent PFs using two “latticeparameters”, the rise (translation along the helical axis,
parallel to the seam) and the twist (rotation around
the helical axis). Additional parameters useful in the
description of theMT lattice are the dimer rise, or “axial
repeat”, which is the distance between dimers along a
PF, and the dimer twist or “MT supertwist”, which
describes the angle between PFs and the axis of the
MT (0 supertwistmeans that the PFs run parallel to the
MT axis).
We prepared cryo-EM samples, following previously
described procedures [11,18], for MT preparations
stabilized by three different MSAs: Taxol, peloruside,
and zampanolide. Table S1 summarizes the results
concerning MT lattice parameters for the different
samples. Comparison with the previously described
GTP-like and GDP (guanosine diphosphate)-state
MTs [11,18] provides a particularly useful context for
understanding the effects of the drugs.
Effect of different MSAs on MT lattice parameters
Previous studies reported that adding Taxol to
unassembled tubulin or to preformed MTs resulted in
different distances between tubulin subunits along
the PF [15], suggesting that the structural effects
of Taxol may be different depending on whether it is
added before tubulin incorporation into the lattice, and
thus beforeGTP hydrolysis, or after MT assembly, and
thus into a preexisting GDP-bound state. To further
explore this possibility, we prepared Taxol-stabilized
MTs for cryo-EM analysis using previously described
protocols [11] but varied the time when the drug
was added (before, i.e., pre-hydrolysis, or after lattice
formation, i.e., post-hydrolysis). Two independent
reconstructions of each sample type have roughly
equivalent resolution (4.0 Å pre-hydrolysis MTs; 3.9 Å
post-hydrolysis MTs;Figs. S1–S2).
Consistent with previous reports [15], the lattice
parameters of theTaxol-MT reconstructions depended
on whether Taxol was added to preformed MTs
(post-hydrolysis state) or unassembled tubulin (pre-
hydrolysis state;Table S1). Although we have data for
MTs ranging from 12 to 15 PFs, we focus here on 13
PFs, as they were the most abundant across all
conditions. Using the dimer axial repeat as a basis for
comparison, our prior work showed that drug-free
GMPCPP-MTs (corresponding to a GTP-like state)
have an “expanded lattice”with an 83.2 Å axial repeat,
whereas dynamic, GDP-bound MTs have a “com-
pacted lattice” with an axial repeat of 81.5 Å [11,18].
Taxol-MTs in which Taxol is added to preformed MTs
haveanaxial repeat of 81.8 Å, very similar to that of the
drug-free MT lattice. However, when added to
unassembled tubulin, Taxol results in a noticeable
lattice expansion, with an axial repeat of 82.3 Å
(Table S1), consistent with a model in which Taxol
inhibits, at least partially, the structural transition that
occurs upon GTP hydrolysis. Although the measured
axial repeat for the pre-hydrolysis Taxol sample is
636 Cryo-EM Structures of Drug-Stabilized Microtubulessmaller than previously reported [11], this state is
consistently observed to be expanded with respect to
the drug-free GDP-MT reconstruction, indicating that
the structural changes, while subtle, are robust.Taxol peloru
Taxol+pelo
A
B
C
Fig. 2. Cryo-EM reconstructions and MSA binding pockets.
left), peloruside (3.9 Å, middle), and zampanolide (4.2 Å, righ
lumen, peloruside-MT from the exterior. (B) Drug-binding sites
(C) Lumen and exterior view of an MT doubly bound to peloru
peloruside binding pockets are shown on the left and right, resIn contrast to Taxol, little is known about how other
drugs, such as zampanolide or peloruside, affect the
MT lattice. To investigate their effect, we performed
similar experiments for both peloruside andside zampanolide
ruside
(A) Structures for MTs bound to Taxol (at 3.9 Å resolution,
t). Taxol- and zampanolide-bound MTs are seen from the
showing the segmented densities for the MSA molecules.
side and Taxol (4.1 Å resolution, middle). The Taxol and
pectively.
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effect of adding the drugs to preformedMTs (due to the
limiting amount of drug). We found that the
zampanolide-MT reconstructions have a similar axial
repeat to that of those bound to Taxol (81.6 Å versus
81.8 Å) and to drug-free MTs (81.5 Å;Table S1).
Peloruside, which binds to a pocket on the MT exterior
(Fig. 1), results in an axial repeat of 81.0 Å. This
difference in MT lattice parameters suggests that
zampanolide andTaxol stabilizeMTs via amechanism
distinct from that of peloruside.
Reconstruction features of drug-stabilized MTs
We obtained near-atomic (3.9–4.2 Å overall)
resolution cryo-EM reconstructions for Taxol-MT
(3.9 Å), peloruside-MT (3.9 Å), doubly bound
(Taxo l a nd pe l o r u s i d e -MT ; 4 . 1 Å ) , a nd
zampanolide-MT structures (4.2 Å)(Fig. 2 and Fig.
S1). Resolution estimates were calculated on the
reconstructions of whole MT segments after impos-
ing pseudo-helical symmetry, as previously de-
scribed [18]. β-strand separation, helical ridges
along alpha helices, and side-chain densities are
visible throughout the majority of the reconstructions
(Fig. S2A), as expected for the estimated resolution
range. Densities for all drug ligands are sufficiently
resolved to conclude that their binding sites agree
with those visualized in previous X-ray crystallo-
graphic studies carried out outside of the MT context
[24,25,33] (Fig. 2).
The Taxol-MT and the peloruside-MT reconstruc-
tions have similar overall resolution, in spite of the
fact that the dataset for Taxol was larger (~23,000
Taxol-MT segments versus ~16,000 peloruside-MT
segments—see Supplementary Materials and
Methods for details;Fig. S1). Furthermore, while in
the Taxol-MT cryo-EM map the luminal surface,
including the Taxol-binding site, is well-defined
(Fig. 2), other tubulin regions, like the MT outside
surface or the β-sheet parallel to the helical axis,
appear more poorly resolved (Fig. S2), indicative of
anisotropic resolution. The same is true of the
zampanolide-MT reconstruction. The taxane recon-
structions (Taxol-MT and zampanolide-MT) have
very different local resolution distributions from those
of the drug-free or peloruside-MT reconstructions
(Fig. 3 and Fig. S3). This difference is most striking
concerning the motor domain of kinesin in the
Taxol-MT and zampanolide-MT reconstructions, for
which resolution is significantly worse (5–5.5 Å) than
for tubulin (3.5–4 Å). In contrast, the peloruside-MT
and peloruside-Taxol-MT reconstructions have more
uniform resolution throughout the structure (Figs. 3A
and Fig. S3), similar to what is seen for drug-free MTs
[18]. The lower resolution of the decorating kinesin in
the Taxol-bound structure is not attributable to low
kinesin occupancy, which we estimate is ≥90% for all
but one of our Taxol datasets (SupplementaryMaterials and Methods and Table S2). Instead, either
the attachment of kinesin is more flexible or the MT
helical lattice is less ordered. The latter would lead to
the averaging of slightly different helical arrangements
and ultimately result in propagating alignment errors
that would blur the density map, especially at higher
radii. In either case, our observation is relevant to
structural and biophysical studies characterizing the
interaction of kinesin and other MAPs with MTs, which
often use Taxol to render MTs resistant to temperature
changes and devoid of dynamic instability.
Taxol-site binders result in lattice heterogeneity
To test for the possibility of conformational hetero-
geneity in the MT lattice, we used RELION to carry out
3D classification of the Taxol-MT, the peloruside-MT,
the zampanolide-MT, and the drug-free MT datasets
(see Supplementary Materials and Methods for
details). The resulting 3D classes for both of the MTs
stabilized by Taxol-site drugs (Taxol-MT and
zampanolide-MT) have visible deformations from a
perfectly circular cross-section of the MT wall that are
not apparent in the peloruside-MT or the drug-free 3D
classes (Movie S1). We quantify the deformations in
the MT walls by taking projections of the resulting 3D
class volumes along the helical axis and computing
elliptical parameters for a set of coordinates represent-
ing the center of each PF in the MT (See Supplemen-
tary Materials and Methods for details). The
coordinates are then fit to the equation for an ellipse.
The resulting short-axis/long-axis ratio represents the
degree to which the MT-PF arrangement, within a
given 3D class volume, deviates from an idealized,
circular MT cross-section. A perfectly circular MT
would producea ratio of 1, since the longaxis and short
axis would be equal. We find that the 3D classes
corresponding to the peloruside-MT or drug-free MTs
(Fig. 3C) have a small spread of ratios (homogeneous
population) andare close to 1 (“circular” cross-section).
However, the 3D classes for Taxol and zampanolide
MTs show a wider range of “elliptical” and continuous
deformations in the MT wall (Fig. 3B–C) that corre-
spond to ~1–2 Å displacement in the position of
tubulin subunits, indicating that the MT walls are more
deformable andmore heterogeneous in comparison to
thepeloruside-MTor drug-free 3Dclasses. This finding
suggests that the observed conformational heteroge-
neity is due toMT-wall flexibility induced by the binding
of a drug to the Taxol site.
Taxol-site binders share common tubulin
interactions
The binding to tubulin of both Taxol and zampa-
nolide has been characterized previously in the
context of an aberrant polymer (zinc-induced 2D
sheets) by electron crystallography for the former
[33] and in the context of unassembled tubulin by
kinesin
Taxol                                       peloruside
resolution (Å)
5.5
5
4.5
4
3.5
A
B C
Fig. 3. Taxol and zampanolide induce MT wall flexibility. (A) End-on view of the cryo-EM reconstructions of Taxol-bound
MTs (left) and peloruside-bound MTs (right). The decorating kinesin, used as a fiducial for the alignment of αβ-tubulin
dimers, is visualized at significantly lower resolution in the Taxol sample (5–5.5 Å) versus peloruside sample (4–4.5 Å),
likely due to alignment errors resulting from wall deformations in the MTs. Regions for which the local resolution of the
decorating kinesin differs significantly are boxed. (B) End-on view of two representative MT classes from the Taxol-bound
(added post-lattice formation) MT sample obtained using RELION 3D sorting. (C) The deformations of the MT wall from a
circular cross-section were approximated as ellipses. The parameters of the elliptical fits to the different 3D classes are
displayed as a ratio between the long and short axes of the ellipse, where a ratio of 1 corresponds to a circle. The red line
indicates the median value, the blue box indicates the 25th and 75th percentiles, and the black lines indicate range of
values for each dataset (n = 5).
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reexamine the modeled interactions between these
two Taxol-site drugs in the context of the physiolog-
ical tubulin polymer, the MT, using our cryo-EM
reconstructions. We will refer to the functional
groups of Taxol and zampanolide using their
numbered carbon atoms (Fig. 1).
The Taxol density is clearly defined in the density
map (Fig. 2B, left) and agrees well with previous
models of Taxol bound to zinc-induced tubulin sheets
[33,34]. Our cryo-EM-based atomic model defines
three critical interactions between tubulin and Taxol
that are well supported by previous pharmacophorestudies (Fig. 4A). First, there are extensive van der
Waals interactions between the 3′-benzoyl of Taxol,
which has been previously shown to be essential
for Taxol's stabilizing activity [35], and β-tubulin
H229 (Fig. 4A). Additionally, the nitrogen in β-H229 is
appropriately positioned to make a hydrogen bond
with Taxol's 3′-oxygen. Second, studies on synthetic
Taxol analogs demonstrated that the 2′-OH group is
crucial to Taxol's activity [35,36]. Removal of this group
causes a 2 orders of magnitude reduction in binding
affinity [35]. We find that Taxol's 2′-OH is close enough
to hydrogen bondwith the backbone carbonyl of R369.
The final interaction involves the β-tubulin backbone
639Cryo-EM Structures of Drug-Stabilized MicrotubulesNH of T276 (in strand S7) making a hydrogen bond
with Taxol's oxetane ring, a group that has also been
shown to be critical for Taxol's stabilizing activity. Other
functional groups, such as the C10 acetyl group and
the C4 acetate, which are less critical for Taxol's
activity [36], do not appear to interact with tubulin in our
model. The C13 side chain, which is widely reported to
be critical but has also been heavily modified in
pharmacological studies [37], is found to interact with
helix H7 by providing hydrophobic contacts, particu-
larly with β-H229, which may explain why hydrophobic
substitutions are tolerated at this site. These findings
are all consistent with the Taxol-binding pocket
described in the electron crystallographic structure
[33]. Interestingly, neither the map density nor the
refined atomic models seem to support direct contacts
between Taxol and theM-loop (Figs. 2A and 4A) in the
MT. A lack of contribution of the M-loop to Taxol
binding/activity is consistent with Taxol binding and
stabilization of zinc-induced tubulin sheets, in which
theM-loop,whichcoordinates the zinc ion, is in a totally
different conformation from that observed in the
context of the MT lattice.
Although the zampanolide reconstruction has lower
resolution (4.2 Å versus 3.9 Å), clear density corre-
sponding to zampanolide is visible, and its binding site
location is in agreement with that reported in the crystal
structure [24]. Density for the full ring can only be seen
at low density thresholds (Fig. 2B, right), perhaps due
to the inherent flexibility of the C1–C4 portion, which
has been shown to have correspondingly higher
crystallographic B-factors [24,38]. Similar to Taxol,
and consistent with crystallographic studies [24],
zampanolide makes specific contacts with β-H229
(through covalent bonding) and β-T276 (throughTaxol zampan
oxetane 
ring
M-loop T276 T276
H6-H7
H229
2’-OH
R369
S9-S10 loop
3’-O
S9
M-loop
H6-H7
A B
Fig. 4. Comparison of the Taxol- and zampanolide-binding p
Taxol interactions marked by the solid green lines. Two o
(B) Zampanolide-binding site highlighting interactions with T27
(C) Superposition of the refined atomic models for Taxol-bou
(blue, with α-tubulin shown in green).hydrogen-bonding interactions with the N-acyl hemi-
aminal group of zampanolide;Fig. 4B), but it does not
appear to interact directly with the M-loop.
We next compare the refined atomic models
corresponding to the two Taxol-site drugs, Taxol and
zampanolide, specifically focusing on the structural
differences around the binding pocket. Taxol binding
appears to give rise to subtle changes in the loops
surrounding the binding pocket when compared to the
drug-free atomic model, most significantly in the S9–
S10 loop (0.53 ÅCα rmsd), whichmoves down toward
the N-site (Fig. 4C); the M-loop moves toward the
Taxolmolecule, and theH6–H7 loopmoves away from
Taxol. In contrast, upon zampanolide binding, the S9–
S10 loop appears to close slightly inward, and the
M-loop adopts a “pushed out” position with respect to
both the drug-free model and the Taxol-bound model.
These differences indicate that while the two drugs
bind the same binding pocket in β-tubulin, their
different structure results in slight differences local to
the binding site, although these differences do not
seem to affect MT lattice parameters.
Peloruside binding affects MT wall curvature,
resulting in a less distinctive seam structure
A previous crystal structure [25] revealed that
peloruside binds at a site that would position it near
the lateral interface between PFs on the MT exterior
(Fig. 1). Our cryo-EM structure further confirms that
proposal. As mentioned before, comparison of the
drug-free MT cryo-EM reconstruction [18] with the
peloruside-MT reconstruction reveals a small change
in axial repeat (81.0 Å versus 81.5 Å; peloruside
versus drug-free) that originates from an apparentS9-S10
M-loop
H6-H7
H7
olide
-S10
H229
C
80°
ockets. (A) Taxol-binding pocket with three critical tubulin–
f these critical contacts are shared with zampanolide.
6 and H229 (marked with green lines) shared with Taxol.
nd (gold), drug-free (purple), and zampanolide-bound MT
640 Cryo-EM Structures of Drug-Stabilized Microtubulesslight compaction of β-tubulin (Table S1). Given the
position of peloruside near the lateral contacts (Fig. 2A,
center), we next looked at its effects on this interface.
When imposing pseudo-helical symmetry (see
Supplementary Materials and Methods) [11,18,39],
we necessarily miss any structural changes that may
occur at the seam, the point where helical symmetry
breaks in theMT lattice. By calculating unsymmetrized
(C1) reconstructions, we previously showed [18] that
drug-free MTs, irrespective of their nucleotide state,
deviate from a perfect cylindrical arrangement due to
the fact that PFs on either side of the seam are further
apart from each other and are slightly rotated with
respect to the rest of the PFs. We find that the drug-
free and peloruside-boundMTC1 reconstructions are
very distinct at the seam (Fig. 5A and Movie S2). The
difference in angle relating to PFs across the seam
in the peloruside-MT reconstruction is smaller by 3°,
and the PFs flanking the seam come closer together,
moving N2 Å (Cα rmsd) toward the MT lumen. As
a consequence, the lateral contact at the seam is
more like those at homotypic contacts, with just ~1 Å
(Cα rmsd) average difference between helical and C1
reconstructions at the seam (Fig. 5A, right). In other
words, the peloruside MT structure is more cylindrical
than the drug-free MT states.
Although the C1 reconstruction is of lower resolu-
tion (4.6 Å), clear density attributable to peloruside
can be seen at every binding pocket, including the
one adjacent to the seam (Fig. 5B, compare left and
right). Although we cannot distinguish between
mechanisms in which peloruside binding would
exert this effect in MT lattice regularization via a
dominant alteration in the heterotypic seam interac-
tions or in the homotypic lateral contacts, our current
analysis shows that the largest structural changes
occur at the seam, indicating that peloruside's most
prominent effect may be to stabilize the MT by
promoting interactions between PFs across to the
seam. The homotypic and heterotypic lateral inter-
actions obtained from the docking of our atomic
model of the peloruside-bound PFs are indistin-
guishable at the present resolution (Fig. 5B).
Theeffect of peloruside on lateral contacts andseam
“regularization” is reminiscent of that seen for MTs
bound to the +TIP protein EB3 [18]. While EB3 binds
across non-seam lateral interfaces but not at the seam,
it results in an angle between PFs that ultimately
repositions those involved in lateral contacts at the
seam, generating a more cylindrical pattern. The
results now obtained for peloruside further support
the idea that the seam may be a weak point within the
MT lattice and that its “cylindrical regularization” by
peloruside may result in MT stabilization.
Peloruside overrides the effects of Taxol binding
Previous studies have proposed that drugs binding
to the Taxol site can biochemically synergize withdrugs that recognize an alternative binding-site, such
as peloruside or laulimalide [30,31]. Additionally,
previous crystal structures of peloruside and epothi-
lone simultaneously bound to tubulin identified a novel
hydrogen-bonding network that was proposed to be
due to allosteric cross-talk between the two binding
sites [25]. We therefore wondered whether a
peloruside-Taxol doubly bound MT structure would
be more similar to either the singly bound Taxol-MT or
the peloruside-MT structures, or an intermediate
between the two. To address this question, we
obtained a reconstruction of the doubly bound
peloruside-Taxol-MT at 4.1-Å resolution (Fig. 2). The
overall resolution of the doubly bound reconstruction is
slightly worse than that of the Taxol-MT reconstruction
(3.9 Å), likely due to the fact that the dataset for the
former was considerably smaller (12,014 versus
21,757 particles; Fig. S1). We find that the doubly
bound peloruside-Taxol-MT has an axial repeat
intermediate between that of the singly bound peloru-
side and Taxol structures (81.5 Å) that originates from
intermediate values for both the intra- and interdimer
distances (TableS1). There is no detectable difference
in structure, at our present resolution, around the
binding pockets for both Taxol and peloruside in the
doubly bound MT compared with the singly bound
structures (Fig. 2, bottom panel), and the critical
interactions between the tubulin and these small
molecules remain seemingly unchanged in the doubly
bound state. Interestingly, the peloruside-Taxol-MT
structure shows a “closed” seam in the unsymmetrized
reconstruction, similar to the effect observed for
peloruside alone, and more closely approximates an
ideal cylindrical PFarrangement (Fig. S4). Additionally,
the reconstruction does not suffer from the lattice
heterogeneity observed in Taxol-MTs (Figs. 3C, S2,
and S3), suggesting that the effects of peloruside
override the effects of Taxol with regard to lateral
interactions.
Biochemical cross-talk between the taxane and
peloruside binding sites
While some biochemical studies have suggested a
synergistic biochemical effect between Taxol and
peloruside binding site ligands [30,31,40], other
studies [41] show little to no influence of laulimalide
binding (which binds at the peloruside site) on the
affinity of Flutax-2 (a bona fide fluorescent paclitaxel
binding site probe) for the taxane site. Since our
structure of the doubly boundMT indicates a dominant
effect of peloruside over Taxol, we decided to further
investigate a possible synergy between peloruside
and Taxol-site binders in their binding affinity to MTs
that could be due to communication between the two
binding sites.
The influence of epothilone A (a bona fide
taxane-site ligand) [42] on the binding of peloruside
to MTs was determined by measuring the binding
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Fig. 5. Structural changes in the MT upon peloruside binding. (A) Cα atoms RMSD (indicated in colors ranging from blue to
red) between atomic models of one helical turn of tubulin dimers for the C1 reconstructions of drug-free and peloruside-bound
MTs (left) and for the pseudo-helically averaged and the asymmetric (C1) reconstructions for peloruside-bound MTs (right). The
red color by the seam reflects the changes in PF orientation that give rise to seam closure in the presence of peloruside. The
changes are minimal when comparing C1 and helical peloruside reconstructions, indicating that the peloruside-bound MTs are
approximated well by an ideal helical arrangement of PFs. (B) Peloruside density is visible at both seam and non-seam binding
pockets in the asymmetric (C1) reconstruction, indicating that peloruside has no preference for homo-(β-β) or hetero-(α-β) tubulin
interactions (top panel contains magnified views of bottom ones).
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seam
drug-free              Taxol-site binders         Taxol&peloruside            peloruside
Fig. 6. Schematic summary of the changes in MT structure induced by MSA binding. Taxol and zampanolide (both
Taxol-site binders) induce lattice heterogeneity (second from left), whereas peloruside promotes a “closed” seam structure
through changes in the lateral contacts that are most notable at the seam (right). Peloruside overrides the effect of Taxol,
resulting in a more ordered lattice and a “closed” seam structure (second from right).
642 Cryo-EM Structures of Drug-Stabilized Microtubulesconstant of peloruside to stabilized and crosslinked
MTs, both with the taxane binding site empty and with
the taxane binding site saturated with epothilone A.
We observed no significant differences between the
binding constant determined in the absence (3.2 ±
0.8 × 106 M−1) or in the presence of epothilone A
(3.5 ± 0.4 × 106 M−1). Reciprocally, the binding con-
stant of epothiloneAwasunaffected by the presence of
peloruside (8.1 ± 0.4 × 107 M−1 in the absence of
peloruside versus 7.5 ± 1 × 107 M−1 in the presence
of peloruside), confirming the observation of Pryor et al.
[41].Discussion
Our cryo-EM studies demonstrate that the MSAs
Taxol, zampanolide, and peloruside have distinct
effects on the MT lattice, indicating different stabiliza-
tion mechanisms. Using 3D classification, we have
identified structural heterogeneity around the MT wall
that is only observed in the presence of Taxol or
zampanolide, which binds to the same taxane site on
β-tubulin (Fig. 6). We infer that this structural hetero-
geneity is due to a small and likely continuous variation
of the lateral contacts between PFs that ultimately
limits the resolution and interpretability of the cryo-EM
reconstructions. This structural flexibility parallels the
greater mechanical flexibil ity observed for
Taxol-stabilized MTs [14,43].
TheMT flexibility induced by Taxol and zampanolide
may be inherent to their mechanism of stabilization, as
has been suggested by molecular dynamic simula-
tions [44]. Taxol-site binding appears to effectively
allow, if not promote, a wider range of conformations of
the lateral contacts without resulting in MT disassem-
bly. A possible explanation may be that more uniform
lateral interfaces are produced when the drug-free MT
is under tension due to the tendency of the tubulin
dimer to curve outwards. Taxol has been shown tostraighten PFs [17] (no information is available for
zampanolide), and thus, a Taxol-MT lattice will not be
under the tension that would otherwise restrict
motions. It is important to note that neither Taxol nor
zampanolide forms direct contacts with the M-loop
involved in lateral contacts. However, they both
establish two critical interactions with tubulin: a
hydrogen bond to the nitrogen backbone of T276
(immediately preceding the M-loop) and critical con-
tacts with H229 in the H7 “core helix”. The functional
groups that form these contacts are known to be critical
for the MT-stabilizing activity of both drugs.
One open question regarding Taxol-site binders is
whether they affect theMT lattice differently, given that
they display a wide range of structural motifs. Our
structures show that Taxol and zampanolide, two
structurally divergent taxane-site binders, affect the
binding pocket in a distinct manner, but without
resulting in differences on the MT lattice. We find that
binding of Taxol results in the expansion of the taxane
binding pocket, while zampanolide binding results in
its tightening, a reflection of the distinctly different
molecular shapes of these two ligands: Taxol is larger,
taking up more space, hence the expansion of the
pocket, and zampanolide is smaller and more com-
pact, hence the tightening of the pocket. In spite of
thesedifferences, two crucial contacts between tubulin
and ligandare preserved in the bindingmodes of Taxol
and zampanolide, namely those with β-tubulin resi-
dues T276 and H229.
In contrast to Taxol and zampanolide, peloruside-
MTs do not exhibit detectable increased heterogeneity
with respect to unbound MTs. Thus, peloruside-
stabilized MTs should be more suitable substrates for
MT-MAP structural studies. Peloruside seems to act
predominantly through strengthening lateral contacts
and altering those at the seam, regularizing the lattice
to more closely resemble a helical structure (Fig. 5). In
this respect, peloruside seems to function similarly to
the plus end binding protein EB3. Both bind between
643Cryo-EM Structures of Drug-Stabilized MicrotubulesPFs and cause the closure of the seam. These findings
support a model in which the seam may be a weak
point within the MT lattice. Interestingly, in the doubly
bound structure analyzed here, the effect of peloruside
on lateral contact regularization is dominant over the
increased flexibility that Taxol causes on its own. This
results in a more helical arrangement of PFs, similar to
what is seen for singly bound peloruside MTs (Fig. 6).
These results and the lack of influence of peloruside
on epothilone A binding to MTs (or vice versa) cannot
explain the cooperative cytotoxicity effects observed
between laulimalide site and taxane-site drugs. How-
ever, in cell assays for cytotoxicity that show cooper-
ative effects [31,45,46], the intracellular ratio of tubulin
to drug is around 100:1 or 50:1, while in our structural
and biochemical studies, the proportion is typically 1:1.
Given the fact that peloruside binding has no effect on
taxane binding and vice versa, the chances that a
single tubulin molecule in the cell has both a molecule
of peloruside and another of taxane bound are far
below 1%. Thus, simultaneous binding cannot be the
reason for the synergistic effect observed in the cellular
context. We propose that the synergy in cytotoxicity is
likely to come from the different structural effects of the
drugs bound at different points along the MT lattice,
which could produce an additive effect on MT stability,
rather than from simultaneous binding of both drugs to
a single tubulin molecule.
The results reported here highlight the complex
structural responses of the MT lattice to differences in
small-molecule structure and binding. Further work will
be required to understand the details of the mecha-
nisms involved in MT stabilization, especially for
compounds that bind the taxane site. However, our
finding that the addition of taxane-site agents to MTs
induces lattice heterogeneity is of immediate relevance
to studies of the interaction of MAPs with MTs. Taxol is
commonly used to stabilize MTs in biophysical and
structural analyses of motors and other MT partners,
and the MT heterogeneity we have described here
needs to be factored in when interpreting data on
MAP-binding or motor protein motility parameters. In
fact, researchers may consider using MT stabilizers
like peloruside, or non-hydrolyzable GTP analogs,
if they are concerned with the possibility that
the Taxol-induced flexibility in the MT lattice could
complicate their conclusions.Materials and Methods
MT assembly and vitrification
MTsamples varied in termsofwhenstabilizing drugs
were added (either before or after polymerization;
Table S1). For each set of conditions, MTs were
prepared from porcine tubulin (Cytoskeleton) at a final
concentration of 0.5 mg/mL (~45 μM) and a finaldrug:tubulin molar ratio of 1.5:3. The formedMTs were
pelleted and then resuspended in EMbuffer containing
the desired drug. In the case of the doubly bound
structure, the MT pellet was first resuspended in
peloruside-containing EM buffer, and then Taxol was
added after approximately 1 min. Due to the very small
amounts of available zampanolide, a slightly different
protocol was used (see Supplementary Materials and
Methods). MTs were decorated with kinesin to aid the
alignment of α- and β- tubulin monomers and to
localize the seam. Sample vitrification and automatic
data collection on a low base Titan microscope (FEI)
equipped with a K2 summit camera (Gatan) were
performed as described previously [18,39] (see
Supplementary Materials and Methods for details).
Image processing
Image processing followed procedures described
previously [11,18,39]. Briefly, MT segments along the
length of a MT were boxed out using overlapping
boxes, each box separated by 80 Å. Global alignment
parameters were obtained against low-pass filtered
(~20 Å) references, comprising 12–15 PF MTmodels.
These parameters were used as inputs for refinement
in FREALIGN [47]. In order to characterize the
structural heterogeneity in each dataset, we employed
RELION 3D classification [48]. See the Supplementary
Materials and Methods for further details.
Model building
The experimental density maps were sharpened
using B-factors of 125–150 Å−1 and filtered to the
estimated resolution using the gold-standard FSC
(Fourier shell correlation). We used as starting atomic
model that of the dynamic and GDP-bound state
without drug from our previous work (PDB: 3JAS) [18].
Ligand conformationswere copied fromhigh-resolution
crystal structures (see Supplementary Materials and
Methods) and were kept fixed, but rigid-body transla-
tions/rotationswere optimized. A 3 × 3 dimer section of
the MT lattice was modeled using Rosetta refinement
[49] as described previously [11] (see also Supple-
mentary Materials and Methods). The lowest 1%
energy models by total score were selected, and a
consensus model was created by averaging back-
bone coordinates and selecting the most common
rotamer. This representativemodel was then refined
against the map using refmac [50] to produce a final
model with optimal geometry and to fit to the map
(see also Supplementary Materials and Methods).
The final models typically deviated from the initial
and starting model by less than 0.5 Å rmsd.
MT-MSA binding affinity
The binding affinity for MTs of epothilone A, a
taxane-site binder, and peloruside, which binds far
644 Cryo-EM Structures of Drug-Stabilized Microtubulesfrom the taxane site, has already been well
characterized [27,42]. In order to determine wheth-
er the binding of peloruside to MTs is allosterically
affected by the occupancy of the distant taxane
site, we measured the binding affinity of peloruside
to MTs, both in the presence or absence of
saturating amounts of epothilone A. We followed
procedures previously described in detail that
measure the affinity of antimitotic agents for cross-
linked, stabilized MTs using centrifugation and
HPLC [27,51]. CrosslinkedMTs (obtained following
previously described procedures [52]) at a concen-
tration of 0.6 μM tubulin in GAB buffer [3.4 M
glycerol, 10 mM sodium phosphate, 1 mM EGTA,
and 6 mM MgCl2 (pH 6.5)] were incubated for
30 min at 25 °C with 0.1 mM GTP and 10 μM of
epothilone A in order to saturate them with this drug
(binding constant of epothilone A for MTs is 7.5 ±
1 × 107 M−1 [42]). Unligated MTs were incubated
for the same time with an equivalent volume of
DMSO (dimethyl sulfoxide). Peloruside (0.1–
10 μM) or an equivalent volume of DMSO was
then added to the samples, followed by a further
incubation for 30 min at 25 °C. The samples were
then centrifuged for 20 min at 25 °C at 50,000 rpm
in a TLA 120.2 rotor (1 ml per sample) in an Optima
TLX centrifuge (Beckman, Palo Alto, CA) to
separate the MTs from the unligated peloruside.
The MT-containing pellets were resuspended in
10 mM NaPi. An internal standard of 10 μM
docetaxel was added to all resuspended pellets
and supernatants, and peloruside and docetaxel
extracted three times with one reaction volume of
CH2Cl2. The extracts were dried and the samples
resuspended in 35 μL (vol/vol) 55% methanol in
water. The amount of compounds was analyzed
using an Agilent 1100 Series instrument employing
a Supelcosil, LC18DBHPLC column of dimensions
250 × 4.6 mm and a bead diameter of 5 μm. The
column was developed with a gradient of 13-min
55% methanol in water, 10-min 70% methanol in
water, and 10-min 55% methanol in water at a flow
rate of 1 mL/min. The absorbance was monitored
at 205 and 230 nm, and the content of peloruside in
the pellets (bound to MTs) and in the supernatant
(free) was determined by comparison with the
known concentration of docetaxel, which is used
as standard. The binding constant of peloruside was
then calculated employing EQUIGRA V5.0 [52] and
compared to both unligated and epothilone-ligated
MTs.
We measured the influence of peloruside on the
binding of epothilone A to MTs similarly, except that
five tubes (5 ml) of each sample were processed,
mixed, and extracted simultaneously to compensate
for the lower concentrations of epothilone A needed,
given the higher binding constant of this compound.
MTs fully saturated with peloruside were obtained by
incubating stabilized and crosslinked MTs (50 nM) for30 min at 25 °C, in GAB buffer containing 0.1 mM
GTP with 50 μM of peloruside (binding constant for
MTs 3.2 ± 0.8 × 106 M−1 [27]). As before, unli-
gated MTs were incubated with an equivalent
volume of DMSO. Epothilone A (0.002 to 1 μM) or
an equivalent volume of DMSO was then added to
the samples, followed by a further incubation for
30 min at 25 °C. The binding constant of epothilone
A was then determined as described above, except
that the extracts were dried and the samples
resuspended in 35 μL (vol/vol) 70% methanol in
water, and the column was developed isocratically
for 30 min with 70%methanol in water at a flow rate
of 1 ml/min and 10 min 55% methanol in water at
1 mL/min. The absorbance was monitored at 220
and 260 nm.
Accession numbers
All electron densitymaps have been deposited in the
EMDB accession numbers EMD-8320, EMD-8321,
EMD-8322, and EMD-8323. Atomic models are
deposited in the PDB accession numbers 5SYC,
5SYE, 5SYF, and 5SYG.
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